Abstract
Adenosine is an endogenous nucleoside available for the diagnosis and treatment of various cardiovascular conditions. It may be given for pharmacologic stress tests as well as administered directly into the coronary arteries during cardiac catheterization. The latter treatment may be utilized to measure fractional flow reserve in addition to treating the no-reflow phenomenon. Adenosine has also been shown to improve the clinical outcome of thrombolytics given in the setting of acute myocardial infarction. Adenosine is a useful agent for evaluation and treatment of the cardiovascular system.
| Original language | English |
|---|---|
| Pages (from-to) | 358-363 |
| Number of pages | 6 |
| Journal | Catheterization and Cardiovascular Interventions |
| Volume | 62 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jul 2004 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- AMI
- AMISTAD trail
- Acute myocardial infarction
- Adenosine
- No-reflow phenomenon
- Noninvasive pharmacologic stress
Fingerprint
Dive into the research topics of 'Cardiovascular drugs: Adenosine role in coronary syndromes and percutaneous coronary interventions'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver